These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31079657)

  • 1. Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?
    de Almeida Filho TP; Maia Filho PA; Barbosa MC; Dutra LLA; Castro MF; Duarte FB; Quixadá ATS; Lemes RPG
    Hematol Transfus Cell Ther; 2019; 41(2):114-118. PubMed ID: 31079657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients.
    Khazaal MS; Hamdan FB; Al-Mayah QS
    Mol Genet Genomic Med; 2019 Aug; 7(8):e809. PubMed ID: 31206255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts.
    Sharma P; Kumar L; Mohanty S; Kochupillai V
    Ann Hematol; 2010 Mar; 89(3):241-7. PubMed ID: 19714331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the type of bcr-abl transcripts and blood cell counts in chronic myeloid leukemia - a possible influence of mdr1 gene expression.
    Balatzenko G; Vundinti BR; Margarita G
    Hematol Rep; 2011 Jan; 3(1):e3. PubMed ID: 22184525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of Bcr-abl type transcript and its relationship with platelet count in Mexican patients with chronic myeloid leukemia].
    Rosas-Cabral A; Martínez-Mancilla M; Ayala-Sánchez M; Vela-Ojeda J; Bahena-Reséndiz P; Vadillo-Buenfil M; Aviña-Zubieta JA; Salazar-Exaire D; Miranda-Peralta E; Marroquín A; Longoria-Revilla E
    Gac Med Mex; 2003; 139(6):553-9. PubMed ID: 14723051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis and comparison of clinicohematological parameters and molecular and cytogenetic response of two Bcr/Abl fusion transcripts.
    Polampalli S; Choughule A; Negi N; Shinde S; Baisane C; Amre P; Subramanian PG; Gujral S; Prabhash K; Parikh P
    Genet Mol Res; 2008 Oct; 7(4):1138-49. PubMed ID: 19048492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of BCR/ABL transcript variants with patients' characteristics in childhood chronic myeloid leukaemia.
    Adler R; Viehmann S; Kuhlisch E; Martiniak Y; Röttgers S; Harbott J; Suttorp M
    Eur J Haematol; 2009 Feb; 82(2):112-8. PubMed ID: 19067742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic-phase chronic myeloid leukemia: Incidence of BCR/ABL transcript and its correlation with presenting features, response to treatment, and survival.
    Laabidi B; Slama N; Ouahchi I; Boufrikha W; Laatiri MA
    Leuk Res Rep; 2023; 20():100373. PubMed ID: 37521582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
    Muddathir AM; Kordofani AA; Fadl-Elmula IM
    Saudi Med J; 2013 Jan; 34(1):29-33. PubMed ID: 23299156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).
    Mundhada S; Luthra R; Cano P
    BMC Cancer; 2004 Jun; 4():25. PubMed ID: 15202948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Major BCR-ABL1 Transcript Type on Clinical and Biological Parameters and Molecular Response in Patients With Chronic Myeloid Leukemia.
    Nachi M; Kihel I; Entasoltane B; Brahimi M; Yafour N; Guella D; Abed A; Bekadja MA
    Hematol Oncol Stem Cell Ther; 2022 Jun; 15(2):58-62. PubMed ID: 32971032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
    Prejzner W
    Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender and BCR-ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia.
    Lin HX; Sjaarda J; Dyck J; Stringer R; Hillis C; Harvey M; Carter R; Ainsworth P; Leber B; Pare G; Sadikovic B
    Eur J Haematol; 2016 Apr; 96(4):360-6. PubMed ID: 26059983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in north Indian chronic myeloid leukemia patients.
    Mir R; Ahmad I; Javid J; Zuberi M; Yadav P; Shazia R; Masroor M; Guru S; Ray PC; Gupta N; Saxena A
    Indian J Cancer; 2015; 52(3):314-8. PubMed ID: 26905124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia.
    Perego RA; Costantini M; Cornacchini G; Gargantini L; Bianchi C; Pungolino E; Rovida E; Morra E
    Eur J Cancer; 2000 Jul; 36(11):1395-401. PubMed ID: 10899653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL fusion genes and laboratory findings in patients with chronic myeloid leukemia in northeast Iran.
    Ayatollahi H; Keramati MR; Shirdel A; Kooshyar MM; Raiszadeh M; Shakeri S; Sadeghian MH
    Caspian J Intern Med; 2018; 9(1):65-70. PubMed ID: 29387322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of BCR-ABL transcript variants in patients with chronic myeloid leukemia: Their correlation with presenting features, risk scores and response to treatment with imatinib mesylate.
    Deb P; Chakrabarti P; Chakrabarty S; Aich R; Nath U; Ray SS; Chaudhuri U
    Indian J Med Paediatr Oncol; 2014 Jan; 35(1):26-30. PubMed ID: 25006280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemogenesis of b2a2-type p210 BCR/ABL in a bone marrow transplantation mouse model using a lentiviral vector.
    Uchida N; Hanawa H; Dan K; Inokuchi K; Shimada T
    J Nippon Med Sch; 2009 Jun; 76(3):134-47. PubMed ID: 19602820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on relationship between different bcr/abl fusion transcripts and clinical manifestations in chronic myeloid leukemia].
    Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Qiu JY; Lu DP; Chen SS
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):347-50. PubMed ID: 12941187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.